Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase.

Stolfi, Carmine

Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase. [electronic resource] - Carcinogenesis Jun 2008 - 1258-66 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1460-2180

10.1093/carcin/bgn122 doi


Animals
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Blotting, Western
Cell Proliferation--drug effects
Colonic Neoplasms--metabolism
Gene Expression--drug effects
Humans
Immunoprecipitation
Mesalamine--pharmacology
Mice
Reverse Transcriptase Polymerase Chain Reaction
S Phase--drug effects
cdc25 Phosphatases--biosynthesis